课题基金 / 基金详情

Development of a Prospective Memory Intervention to Reduce Drug Use and HIV Risk

Development of a Prospective Memory Intervention to Reduce Drug Use and HIV Risk
开发前瞻性记忆干预措施以减少吸毒和艾滋病毒风险
批准号:
8735112
负责人:
Matthew Wayne Johnson
金额:
$50.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-30 至 2016-06-30

项目摘要

项目成果

Matthew Wayne Johnson的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):吸毒和相关的艾滋病毒危险行为是重大的公共卫生问题,大多数成瘾治疗未能产生持久的行为改变。前瞻记忆(未来实现意图的能力;例如,记得服药、参加预定的会议)可能在行为改变中发挥关键作用,例如在成瘾治疗中(即,为了改变行为,一个人必须记住不同的行为)。尽管前瞻记忆在成瘾和吸毒者前瞻记忆受损的发现中起到了直观的作用,但还没有研究针对前瞻记忆进行治疗。前瞻记忆还提供了一种机制,解释了令人兴奋但在理论上具有挑战性的发现,即工作记忆训练减少了成瘾者的延迟折扣(在实验室任务中,人们通过选择较大的较晚奖励而不是较小的较早奖励来表现出更强的自控力),并减少了酗酒者的饮酒。前瞻记忆(依赖于工作记忆)是缺失的一环,因为更大的工作记忆容量更有可能有空间来记住长期目标(前瞻记忆),同时面临其他需求,包括与长期目标冲突的诱惑。改善前瞻记忆会让人更成功地获得长期奖励,随着时间的推移,这会强化延迟奖励的更高价值。工作记忆训练只能解决前瞻记忆的多个组成部分中的一个。因此,这一极具创新性的提议将开发第一次前瞻记忆训练,以涵盖前瞻记忆的多个组成部分(工作记忆、回溯记忆、执行功能),以提高自控力(等待延迟奖励的能力),从而减少药物使用和相关的艾滋病毒风险行为。计算机化的前瞻记忆训练将使用沉浸式技术来模拟日常生活中的前瞻记忆挑战。3对使用可卡因的美沙酮患者的研究将从基础研究转向临床干预的精细化。实验1将通过为后续实验(目标1a)确定预期记忆任务(意图记忆)的最佳数量来通知干预发展。实验2是对前瞻记忆训练改善前瞻记忆这一假设的“概念证明”检验(目标2a),并将提供“剂量-反应”信息以确定最佳训练次数(目标2b)。实验3为随机对照试验(3组:前瞻记忆训练、工作记忆训练、对照),检验前瞻记忆训练对改善目标行为的初步效果。我们假设,与对照相比,前瞻性记忆训练将减少延迟折扣(目标3a;主要)、药物使用和艾滋病毒危险行为(目标3b;次要)。第二个假设是,前瞻记忆训练会比工作记忆训练在延迟折扣上产生更大的减少。除了药物依赖和艾滋病毒,该项目的数据对于预防和治疗行为改变至关重要的许多临床疾病(肥胖症、心血管疾病、癌症、糖尿病)具有广泛的影响。
英文摘要
DESCRIPTION (provided by applicant): Drug addiction and associated HIV risk behavior are significant public health problems, and most addiction treatments fail to produce lasting behavior change. Prospective memory (ability to implement an intention in the future; e.g., remember to take medication, attend a scheduled meeting) may play a critical role in behavior change such as in addiction treatment (i.e., in order to behave differently, one has to remember to behavior differently). Despite an intuitive role for prospective memory in addiction and findings of impaired prospective memory in drug abusers, no study has targeted prospective memory for treatment. Prospective memory also provides a mechanistic account of exciting but theoretically challenging findings that working memory training decreased delay discounting (people showed greater self-control by choosing larger later rewards over smaller sooner rewards in a lab task) in addicted individuals, and reduced drinking in alcoholics. Prospective memory (which relies on working memory) is the missing link because a larger working memory capacity is more likely to have space to hold long term goals in mind (prospective memory) while faced with other demands including temptations at conflict with those longer term goals. Improved prospective memory results in a person more successfully obtaining longer term rewards, which over time reinforces greater valuation of delayed rewards. Working memory training only addresses 1 of multiple components of prospective memory. Thus, this highly innovative proposal will develop the 1st prospective memory training to encompass the multiple components of prospective memory (working memory, retrospective memory, executive functions), in order to increase self- control (ability to wait for delayed rewards), and therefore reduce drug use and associated HIV risk behavior. The computerized prospective memory training will use immersive technology to simulate everyday life prospective memory challenges. 3 studies in methadone patients who use cocaine will move from basic research to refinement of clinical intervention. Exp. 1 will inform intervention development by determining the optimal # of prospective memory tasks (intentions to remember) for subsequent experiments (Aim 1a). Exp. 2 is a 'proof of concept' test of the hypothesis that prospective memory training improves prospective memory (Aim 2a), and will provide 'dose-response' information to determine the optimal # of training sessions (Aim 2b). Exp. 3 is a randomized controlled trial (3 groups: prospective memory training, working memory training, control) to test the preliminary efficacy of the prospective memory training to improve the target behaviors. We hypothesize that prospective memory training will decrease delay discounting (Aim 3a; primary), drug use, and HIV risk behavior (Aim 3b; secondary), relative to control. A secondary hypothesis is that prospective memory training will produce greater decreases in delay discounting than working memory training. In addition to drug dependence and HIV, data from this project have broad implications for prevention and treatment of the many clinical disorders in which behavior change is critical (obesity, cardiovascular disease, cancer, diabetes).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
  • 批准号:
    10187739
  • 项目类别:
  • 资助金额:
    $149.94万
  • 财政年份:
    2021
  • 负责人:
    Matthew Wayne Johnson
  • 依托单位:
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
  • 批准号:
    10491336
  • 项目类别:
  • 资助金额:
    $154.48万
  • 财政年份:
    2021
  • 负责人:
    Matthew Wayne Johnson
  • 依托单位:
Greenwashing cigarettes: Perceptual and behavioral evidence of inaccurate modified risk advertising
  • 批准号:
    9980558
  • 项目类别:
  • 资助金额:
    $49.13万
  • 财政年份:
    2020
  • 负责人:
    Matthew Wayne Johnson
  • 依托单位:
Greenwashing cigarettes: Perceptual and behavioral evidence of inaccurate modified risk advertising
  • 批准号:
    10170306
  • 项目类别:
  • 资助金额:
    $48.27万
  • 财政年份:
    2020
  • 负责人:
    Matthew Wayne Johnson
  • 依托单位:
海外基金